Treating Refractory Hypertension: Renal Denervation With High-Resolution 3D-Angiography

Authors Information
Article Notes and Dates
To Cite : Alegria-Barrero E, Teijeiro R, Casares M, Vega M, A Blazquez M, et al. Treating Refractory Hypertension: Renal Denervation With High-Resolution 3D-Angiography, Res Cardiovasc Med. 2013 ;2(2):106-8. doi: 10.5812/cardiovascmed.9700.
Abstract
1. Introduction
2. Case Report
3. Discussion
Acknowledgements
Footnotes
References
  • 1. Krousel-Wood M, Muntner P, Carson A, Anderson AH, Delaune E, Cushman WC, et al. Hypertension control among newly treated patients before and after publication of the main ALLHAT results and JNC 7 guidelines. J Clin Hypertens (Greenwich). 2012; 14(5): 277-83[DOI][PubMed]
  • 2. Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne AP, et al. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens. 2011; 29(1): 4-16[DOI][PubMed]
  • 3. DiBona GF. Functionally specific renal sympathetic nerve fibers: role in cardiovascular regulation[ast]. Am J Hypertens. 2001; 14: 163S-170S
  • 4. Esler M. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp Physiol. 2011; 96(7): 611-22[DOI][PubMed]
  • 5. Noll G, Wenzel RR, Schneider M, Oesch V, Binggeli C, Shaw S, et al. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation. 1996; 93(5): 866-9[PubMed]
  • 6. Symplicity H.T.N.I., Esler M.D., Krum H., Sobotka P.A., Schlaich M.P., chmieder R.E., et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. The Lancet. 2010; 376(9756): 1903-9
  • 7. Krum H, Schlaich MP, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. The Lancet. 2009; 373(9671): 1275-1281
  • 8. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011; 123(18): 1940-6[DOI][PubMed]
  • 9. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009; 361(9): 932-4[DOI][PubMed]
  • 10. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011; 57(5): 911-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Research in Cardiovascular Medicine accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check